Kernal is creating mRNA therapies that instruct specific cells on how to make their own drugs to cure an illness. Today, we are targeting cancer, but this platform can be used for a number of other illnesses, too. With roots at MIT, Harvard and Bio Pharma, the team previously built a successful Biotech company and has deep technical expertise in mRNA and oncology space.